By G HossainPosted on November 6, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs After the FDA delayed a decision for Agios Pharmaceuticals’ sickle cell disease candidate, the biopharma is letting go of more than 35% of its R&D employees. Agios axes 100-plus R&D roles while awaiting FDA decision Post navigation Sarepta’s new CEO confident in clinical execution as DMD competitors close inForge’s Piteri-Molina on AI, Ohio and what’s next for gene therapy manufacturing
